Correlation Between Speakeasy Cannabis and Antisense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Speakeasy Cannabis and Antisense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Speakeasy Cannabis and Antisense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Speakeasy Cannabis Club and Antisense Therapeutics Limited, you can compare the effects of market volatilities on Speakeasy Cannabis and Antisense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Speakeasy Cannabis with a short position of Antisense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Speakeasy Cannabis and Antisense Therapeutics.
Diversification Opportunities for Speakeasy Cannabis and Antisense Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Speakeasy and Antisense is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Speakeasy Cannabis Club and Antisense Therapeutics Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Antisense Therapeutics and Speakeasy Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Speakeasy Cannabis Club are associated (or correlated) with Antisense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Antisense Therapeutics has no effect on the direction of Speakeasy Cannabis i.e., Speakeasy Cannabis and Antisense Therapeutics go up and down completely randomly.
Pair Corralation between Speakeasy Cannabis and Antisense Therapeutics
Assuming the 90 days horizon Speakeasy Cannabis Club is expected to under-perform the Antisense Therapeutics. But the pink sheet apears to be less risky and, when comparing its historical volatility, Speakeasy Cannabis Club is 3.02 times less risky than Antisense Therapeutics. The pink sheet trades about -0.06 of its potential returns per unit of risk. The Antisense Therapeutics Limited is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 6.50 in Antisense Therapeutics Limited on August 25, 2024 and sell it today you would lose (2.30) from holding Antisense Therapeutics Limited or give up 35.38% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Speakeasy Cannabis Club vs. Antisense Therapeutics Limited
Performance |
| Timeline |
| Speakeasy Cannabis Club |
| Antisense Therapeutics |
Speakeasy Cannabis and Antisense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Speakeasy Cannabis and Antisense Therapeutics
The main advantage of trading using opposite Speakeasy Cannabis and Antisense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Speakeasy Cannabis position performs unexpectedly, Antisense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Antisense Therapeutics will offset losses from the drop in Antisense Therapeutics' long position.| Speakeasy Cannabis vs. Benchmark Botanics | Speakeasy Cannabis vs. City View Green | Speakeasy Cannabis vs. BC Craft Supply | Speakeasy Cannabis vs. Ravenquest Biomed |
| Antisense Therapeutics vs. Amexdrug | Antisense Therapeutics vs. Aion Therapeutic | Antisense Therapeutics vs. Alterola Biotech | Antisense Therapeutics vs. The BC Bud |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |